Manhattan Beach NY Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Manhattan Beach NY
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Manhattan Beach NY News
IonQ (NYSE: IONQ), the world’s leading quantum company, today announced a strategic agreement with the University of Chicago to establish the IonQ Center for Engineering and Science on campus and ...
How Manhattan-sized 3I/ATLAS comet could actually help protect Earth from future asteroids
Contrary to allegations that 31/ATLAS is potentially hostile alien tech, the Manhattan-sized comet could provide potentially Earth-saving intel. Researchers claim that a NASA-backed campaign to track ...
One Of The Best Canceled Sci-Fi Shows Of The '90s Was Also Deeply Hilarious
The 1990s sci-fi series Now and Again only lasted one season and feels pretty much forgotten these days, but it deserved better.
SF Thiel Fellow Jumps Coasts To Build Gene-Edited Baby Startup Manhattan Genomics
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human embryos.